Oscotec Inc Cash Flow Conversion Efficiency

Latest as of June 2026: 0.222x

Oscotec Inc cash flow conversion efficiency. Based on the latest financial reports, Oscotec Inc (039200) has a cash flow conversion efficiency ratio of 0.222x as of June 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (₩49.80 Billion ≈ $33.75 Million USD) by net assets (₩224.12 Billion ≈ $151.88 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Cash Flow Conversion Efficiency of Oscotec Inc (2011–2025)

Cash flow conversion efficiency of Oscotec Inc from 2011 to 2025. This chart illustrates how Oscotec Inc's cash flow conversion efficiency has evolved over time, based on yearly financial data. View 039200 live share price for real-time trading data and today's change.

Oscotec Inc Cash Flow Conversion Ratio Explained

Oscotec Inc cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.

Oscotec Inc Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Oscotec Inc ranked by their cash flow conversion efficiency. Also see Oscotec Inc (039200) market capitalisation for the company's overall valuation and market capitalisation.

Company	Cash Flow Conversion Efficiency
Heilongjiang ZBD Pharmaceutical Co Ltd SHG:603567	0.046x
Risesun Real Estate Development Co Ltd SHE:002146	-0.025x
Naphtha TA:NFTA	0.097x
Dark Horse Beijing Technology Co Ltd SHE:300688	-0.034x
Sabre Corpo NASDAQ:SABR	-0.034x
Liaoning Oxiranchem Inc SHE:300082	-0.012x
AEVEX Corp. NYSE:AVEX	-0.033x
PennantPark Floating Rate Capital Ltd NYSE:PFLT	0.134x

Annual Cash Flow Conversion Efficiency for Oscotec Inc (2011–2025)

The table below shows the annual cash flow conversion efficiency of Oscotec Inc from 2011 to 2025. Review Oscotec Inc (039200) free cash flow to assess how much free cash flow the company generates relative to operating cash flow.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-12-31	₩186.85 Billion ≈ $126.62 Million	₩8.30 Billion ≈ $5.63 Million	0.044x	+122.59%
2024-12-31	₩132.36 Billion ≈ $89.70 Million	₩-26.03 Billion ≈ $-17.64 Million	-0.197x	+15.50%
2023-12-31	₩94.72 Billion ≈ $64.19 Million	₩-22.05 Billion ≈ $-14.94 Million	-0.233x	-7.93%
2022-12-31	₩122.51 Billion ≈ $83.02 Million	₩-26.42 Billion ≈ $-17.91 Million	-0.216x	+29.04%
2021-12-31	₩28.83 Billion ≈ $19.54 Million	₩-8.76 Billion ≈ $-5.94 Million	-0.304x	+9.83%
2020-12-31	₩53.05 Billion ≈ $35.95 Million	₩-17.88 Billion ≈ $-12.12 Million	-0.337x	-63035.38%
2019-12-31	₩51.29 Billion ≈ $34.76 Million	₩27.47 Million ≈ $18.62K	0.001x	+100.49%
2018-12-31	₩46.29 Billion ≈ $31.37 Million	₩-5.08 Billion ≈ $-3.44 Million	-0.110x	+36.83%
2017-12-31	₩21.24 Billion ≈ $14.40 Million	₩-3.69 Billion ≈ $-2.50 Million	-0.174x	+44.31%
2016-12-31	₩26.33 Billion ≈ $17.84 Million	₩-8.21 Billion ≈ $-5.56 Million	-0.312x	-1397.65%
2015-12-31	₩26.92 Billion ≈ $18.24 Million	₩646.84 Million ≈ $438.35K	0.024x	+126.68%
2014-12-31	₩21.78 Billion ≈ $14.76 Million	₩-1.96 Billion ≈ $-1.33 Million	-0.090x	-166.09%
2012-12-31	₩24.47 Billion ≈ $16.58 Million	₩3.34 Billion ≈ $2.26 Million	0.136x	+832.77%
2011-12-31	₩25.73 Billion ≈ $17.43 Million	₩375.90 Million ≈ $254.74K	0.015x	--

About Oscotec Inc

KQ:039200 Korea Pharmaceuticals

Market Cap

$674.16 Million

₩994.80 Billion KRW

Market Cap Rank

#10371 Global

#269 in Korea

Share Price

₩35400.00

Change (1 day)

+0.00%

52-Week Range

₩28000.00 - ₩62000.00

All Time High

₩66971.21